Medicure Inc. (NGQ1)
XDUS
Closed
Oct 8, 2026
Day's Range
1.8152 wk Range
0.5000Overview - NGQ1 - Medicure Inc.
Key Statistics
Valuation
Enterprise Value
-2.94M
P/E (Trailing)
‪-2.38‬
PEG Ratio
‪-0.03‬
Price / Book
‪1.42‬
EV / EBITDA
‪0.72‬
Profitability
Gross Margin
‪43.05%‬
Profit Margin
‪40.71%‬
Operating Margin
‪-23.69%‬
Return on Assets
‪-28.44%‬
Return on Equity
‪-54.97%‬
Ownership
Shares Outstanding
10.43M
Price stats
50-Day Avg
‪1.04‬
200-Day Avg
‪0.7671‬
Peers - NGQ1 - Medicure Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XDUS.
- NGQ1XDUSMedicure Inc.+65.12%52-week change-2.38P/E (Trailing)‪40.71%‬Profit Margin
- PA8XDUSPaion AG+74.75%52-week change-0.76P/E (Trailing)‪94.10%‬Profit Margin
- 6CWXDUSCharlottes Web Holdings Inc.+69.26%52-week change-1.28P/E (Trailing)‪43.48%‬Profit Margin
- 20MPXDUSThe More Life Company Corp.+67.44%52-week change-3.44P/E (Trailing)—Profit Margin
- HLSXDUSAIC Mines Limited+59.24%52-week change—P/E (Trailing)—Profit Margin
- I76XDUSIronwood Pharmaceuticals, Inc. Class A Common Stock+59.06%52-week change21.33P/E (Trailing)—Profit Margin
- E7PXDUSIndivior Pharmaceuticals, Inc.+54.46%52-week change18.69P/E (Trailing)‪80.14%‬Profit Margin
Profile Summary - NGQ1 - Medicure Inc.
About
Medicure Inc. is a pharmaceutical company engaged in the development and commercialization of therapeutics for the cardiovascular market. Its primary focus is on providing innovative and cost-effective therapies that improve the health outcomes of patients with cardiovascular diseases. This company is known for its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
